Krummnow, A.; Danzer, A.; Voges, K.; Dohrn, S.; Kyeremateng, S.O.; Degenhardt, M.; Sadowski, G.
Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics 2022, 14, 1904.
https://doi.org/10.3390/pharmaceutics14091904
AMA Style
Krummnow A, Danzer A, Voges K, Dohrn S, Kyeremateng SO, Degenhardt M, Sadowski G.
Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics. 2022; 14(9):1904.
https://doi.org/10.3390/pharmaceutics14091904
Chicago/Turabian Style
Krummnow, Adrian, Andreas Danzer, Kristin Voges, Stefanie Dohrn, Samuel O. Kyeremateng, Matthias Degenhardt, and Gabriele Sadowski.
2022. "Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions" Pharmaceutics 14, no. 9: 1904.
https://doi.org/10.3390/pharmaceutics14091904
APA Style
Krummnow, A., Danzer, A., Voges, K., Dohrn, S., Kyeremateng, S. O., Degenhardt, M., & Sadowski, G.
(2022). Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions. Pharmaceutics, 14(9), 1904.
https://doi.org/10.3390/pharmaceutics14091904